Global Advisory Committee on Vaccine Safety, 2-3 December 2004.
D000276:Adjuvants, Immunologic / Q000009:adverse effects; D026683:Advisory Committees; D001321:Autistic Disorder / Q000209:etiology; D007562:Creutzfeldt-Jakob Syndrome / Q000517:prevention & control; D014943:Global Health; D006801:Humans; D012449:Safety / Q000592:standards*; D022541:Streptococcal Vaccines / Q000009:adverse effects; D013849:Thimerosal / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects* / Q000737:chemistry / Q000592:standards; D014944:World Health Organization; D022341:Yellow Fever Vaccine / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D022541:Streptococcal Vaccines; D014612:Vaccines; D022341:Yellow Fever Vaccine; C488512:hexavalent group A streptococcal vaccine; D013849:Thimerosal